These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11330337)

  • 21. Muscarinic receptor alterations as a mechanism of anticholinesterase tolerance.
    Schwab BW; Costa LG; Murphy SD
    Toxicol Appl Pharmacol; 1983 Oct; 71(1):14-23. PubMed ID: 6636179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands.
    Ben-Barak J; Gazit H; Silman I; Dudai Y
    Eur J Pharmacol; 1981 Aug; 74(1):73-81. PubMed ID: 7318895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
    Messer WS; Ellerbrock B; Price M; Hoss W
    Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW; Smith MM; Harden TK
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of paired M2 muscarinic receptors.
    Potter LT; Ballesteros LA; Bichajian LH; Ferrendelli CA; Fisher A; Hanchett HE; Zhang R
    Mol Pharmacol; 1991 Feb; 39(2):211-21. PubMed ID: 1899905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic acetylcholine receptors on rat thymocytes: their possible involvement in DNA fragmentation.
    Yamada T; Murayama T; Nomura Y
    Jpn J Pharmacol; 1997 Apr; 73(4):311-6. PubMed ID: 9165367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogenic distribution of muscarinic receptors and acetylcholinesterase in the rabbit hippocampus.
    Nio J; Besson MJ; Breton P
    Brain Res Bull; 1993; 31(6):723-32. PubMed ID: 8518962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of choline with nicotinic and muscarinic cholinergic receptors in the rat brain in vitro.
    Costa LG; Murphy SD
    Clin Exp Pharmacol Physiol; 1984; 11(6):649-54. PubMed ID: 6536422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents.
    Costa LG; Kaylor G; Murphy SD
    Int J Immunopharmacol; 1990; 12(1):67-75. PubMed ID: 2303319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different interactions of steric isomers of hexobarbital to muscarinic agonist and antagonist binding sites in brain.
    Nordberg A; Wahlström G
    Brain Res; 1984 Sep; 310(1):189-92. PubMed ID: 6089967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos.
    Chaudhuri J; Chakraborti TK; Chanda S; Pope CN
    J Biochem Toxicol; 1993 Dec; 8(4):207-16. PubMed ID: 7509414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High affinity binding of [3H]acetylcholine to muscarinic receptors. Regional distribution and modulation by guanine nucleotides.
    Gurwitz D; Kloog Y; Sokolovsky M
    Mol Pharmacol; 1985 Sep; 28(3):297-305. PubMed ID: 4033630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulatory effects of phosphatidylserine on the binding of muscarinic cholinergic receptor ligands. Studies in vitro and in vivo.
    Raskovsky S; Rivas E; Bernik D; Medina J; Jerusalinsky D
    Mol Chem Neuropathol; 1990; 13(1-2):17-32. PubMed ID: 2095782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.